# OnCo record nct06828991 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06828991/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06828991", "NCT06828991" ;
  schema:name "A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHP"@en ;
  schema:description "A phase 2 trial of Mosunetuzumab and clonoSEQ in Diffuse large B-cell lymphoma, run by Danielle Wallace, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06828991/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06828991> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:drugs <https://onco.cc/drugs/mosunetuzumab/>, <https://onco.cc/drugs/clonoseq/> .